Unichem wishes to expand its current range of Pain Management formulations by partnering with companies and manufacturing / marketing their products under license, for the high potential Indian market.

Unichem has significant equity among specialists focused on pain management. Our current range of products spreads across a wide spectrum of products for pain management.

Major formulations manufactured and marketed are categorized as Anti-Arthritic, Anti-Osteoporosis, Anti-Rheumatic, Non-Narcotic-antipyretics, Muscle relaxants. In these segments, the company seeks NDDS versions (including those for sustained release) of various regular formulations. So also, in some our non-represented segments among diclofenac-based combinations, aceclofenac-based combinations, baclofen-based combinations, and various formulations which could be of interest to the specialists who we cover for pain management.

In the highly competitive and fragmented Indian market, Unichem has an enviable franchise among Orthopaedicians, Rheumatologists, Cardiologists, Diabetologists, ENT specialists, Neurologist, Psychiatrists, Dermatologists, Nephrologists, General Practitioners and Consulting Physicians. Unichem brands feature among the Top prescribed brands in many therapeutic categories.

Unichem's marketing and sales infrastructure is divided into various divisions, each focusing on key therapeutic segments. In India, we have a collective field force strength of around 1500. This 1500-strong team meets about 150,000 doctors located across the length and breadth of India.

Our strong logistics network helps reach out to every nook and corner of this large sub-continent, through 42 distributors, over 4500 stockists and through the stockists to around 500,000 retail chemists. Lead time for physical launch of new products would thus be minimal.

Unichem's world class manufacturing facilities at our various locations enjoy global accreditations, such as USFDA, MHRA, MCC, ANVISA, TGA, WHO, and our systems are certified for ISO 9001:2000 and ISO 14000:2004. With adequate capacities to ensure prompt servicing of various markets, Unichem's investments have ensured the right infrastructure for future formulations and API requirements.

We have a proven capability to nurture and grow formulations to leadership positions, and would be successful in launching formulations of our prospective partners

 

Registered

• Manufacturing and marketing
• Manufacturing
• Marketing
• Co-marketing
• Distribution
• (All above under appropriate licensing arrangement)